• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Largest Options Expiry: Can Bitcoin Reach $100,000?

user avatar

by Giorgi Kostiuk

a year ago


On November 29, Bitcoin will face its largest options expiry of 2024, with a total exposure of $13.6 billion. It is crucial to assess its potential impact on the market.

Current Market Situation

The S&P 500 has struggled to maintain levels above 6,000 over the past three weeks. The U.S. market also indicates a growing investor caution. Meanwhile, the 5-year Treasury yield has dropped from 4.35% to 4.12%, highlighting the preference for safer assets.

Bitcoin Options: Aggregate Figures

As of November 29, the aggregated notional value of call (buy) options will reach $7.4 billion compared to $6.2 billion for put (sell) options. This disparity is less pronounced than typical, indicating notable interest in Bitcoin from traders.

Temporary and uncertain tariffs of this nature create natural incentives to delay investments.Barclays

Four Potential Scenarios for the Market

The analysis covers four potential scenarios for the Deribit exchange based on different Bitcoin price levels. For instance, if the price stays between $86,000 and $90,000, the net outcome favors call options by $1.65 billion. The greatest benefit of $4.58 billion is expected if the price is between $98,000 and $102,000.

Bitcoin demonstrates resilience amid economic challenges. This could lead to prices reaching $100,000 after these options expire.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Disney's $1 Billion Investment in OpenAI Marks a New Era in Entertainment

chest

The Walt Disney Company has announced a groundbreaking $1 billion equity investment in OpenAI, marking a significant partnership to enhance AI-driven storytelling in entertainment.

user avatarElias Mukuru

Rezolute, Inc. Shares Plummet 90% Following Disappointing Clinical Trial Results

chest

Rezolute, Inc. shares dropped 90% after disappointing Phase 3 clinical trial results for the therapy ersodetug.

user avatarDiego Alvarez

Rezolute Plans FDA Discussions Despite Clinical Trial Setback

chest

Rezolute plans to meet with the FDA to discuss next steps for ersodetug development following disappointing Phase 3 trial results.

user avatarKenji Takahashi

Nexo Faces Regulatory Challenges in South America

chest

Nexo must navigate complex regulatory landscapes in South America to establish its services.

user avatarMiguel Rodriguez

Nexo Acquires Buenbit to Expand in South America

chest

Nexo has acquired Argentine fintech Buenbit, marking a significant expansion into the South American crypto market.

user avatarGustavo Mendoza

Matthew Perry Remains Confident in JasmyCoin's Long-Term Potential

chest

Matthew Perry remains confident in JasmyCoin's long-term potential despite recent price drops.

user avatarRajesh Kumar

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.